Wellington Management Group
AUTL

Wellington Management Group’s Autolus Therapeutics AUTL Stock Holding History

Wellington Management Group’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,147,035
Closed -$61.9M – 1981
2025
Q2 		$61.9M Buy
27,147,035
+55,335
+0.2% +$91.5K 0.01% 637
2025
Q1 		$42M Buy
27,091,700
+1,746,020
+7% +$3.54M 0.01% 731
2024
Q4 		$59.6M Buy
25,345,680
+1,125,454
+5% +$3.8M 0.01% 660
2024
Q3 		$87.9M Buy
24,220,226
+6,330,392
+35% +$25.2M 0.02% 567
2024
Q2 		$62.3M Buy
17,889,834
+7,126,833
+66% +$30.8M 0.01% 649
2024
Q1 		$68.7M Buy
+10,763,001
New +$67.1M 0.01% 625

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group's AUTL Position: Q3 2025 in Review

Wellington Management Group sold out of Autolus Therapeutics (AUTL) in Q3 2025, closing a stake of 27,147,035 shares — an estimated $61.9M sold.

Wellington Management Group first reported a position in AUTL in Q1 2024 and held it in 6 quarters. The position peaked at $87.9M in Q3 2024. 96 funds tracked by Wall St. Rank hold AUTL as of Q3 2025.

  • Wellington Management Group reported no remaining Autolus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wellington Management Group sold 27,147,035 Autolus Therapeutics shares in Q3 2025, an estimated $61.9M.
  • Wellington Management Group first reported a position in Autolus Therapeutics in Q1 2024 and held it in 6 quarters.
  • Wellington Management Group's Autolus Therapeutics position peaked at $87.9M in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.